In addition, the obesity drug also improved knee pain in participants, Eli Lilly noted. ・Seven additional Phase 3 trials for ...

The average participant getting a 12-mg weekly injection lost 71 pounds in 68 weeks.  "This is beyond what we see with any ...

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

Eli Lilly has unveiled a new weight loss drug that appears to be delivering the highest weight loss yet in clinical trials ...

A new study has found the non-invasive application of in-ear electrical stimulation to the vagus nerve to be safe and effective in reducing osteoarthritis-related knee pain. It opens the door to ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

The event also highlights the importance of non-opioid therapies for managing both acute and chronic pain. Pacira BioSciences ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering ...

ORANGE, Calif. (KABC) -- The cartilage around your knee allows it to glide smoothly as you bend and straighten, but once it's torn it can cause excruciating pain. Local doctors are now investigating a ...

A mainstay diabetes medication reduced pain and stiffness and improved function in overweight people with knee osteoarthritis, a new study has found. Effective pain reduction and improved mobility may ...

Seniors who garden are less likely to have knee pain or show evidence of knee arthritis in X-rays, researchers reported in a ...

The inexpensive diabetes pill metformin significantly reduced pain from knee osteoarthritis in a small trial of people who are overweight or have obesity. Results from a small trial suggest that the ...